According to Cytokinetics 's latest financial reports the company's current EPS (TTM) is -ยฃ4.43. In 2022 the company made an earnings per share (EPS) of -ยฃ3.31 a decrease over its 2021 EPS that were of -ยฃ2.20.
Year | EPS | Change |
---|---|---|
2023 (TTM) | -ยฃ4.74 | 43.26% |
2022 | -ยฃ3.31 | 50.18% |
2021 | -ยฃ2.20 | 40.8% |
2020 | -ยฃ1.56 | -4.74% |
2019 | -ยฃ1.64 | 8.21% |
2018 | -ยฃ1.52 | -24.12% |
2017 | -ยฃ2.00 | -776.32% |
2016 | ยฃ0.30 | -139.18% |
2015 | -ยฃ0.75 | 125.58% |
2014 | -ยฃ0.33 | -67.67% |
2013 | -ยฃ1.03 | -44.58% |
2012 | -ยฃ1.87 | -44.95% |
2011 | -ยฃ3.39 | -6.84% |
2010 | -ยฃ3.64 | -290.24% |
2009 | ยฃ1.91 | -135.96% |
2008 | -ยฃ5.32 | 10.68% |
2007 | -ยฃ4.81 | -33.97% |
2006 | -ยฃ7.28 | 5.41% |
2005 | -ยฃ6.91 | -60.64% |
2004 | -ยฃ17.55 | -77.21% |
2003 | -ยฃ77.01 |